MedTrace Logo

Clinical Evaluation of the Effect of Duodenal-Jejunal Bypass on Type 2 Diabetes

NCT00694278 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2008-06-10

No results posted yet for this study

Summary

The aim of this study and the primary outcome is to clinically evaluate effect of laparoscopic duodenal-jejunal bypass on non-obese type 2 diabetes. Secondary outcomes will evaluate CCK, FFA, Cholesterol Ghrelin, C-peptide, and HbA1c levels. Patients will be followed closely to ensure the desired results are sustained in long term

Conditions

  • Type II Diabetes

Sponsors & Collaborators

  • Ferzli, George S., M.D. F.A.C.S.

    lead INDIV

Principal Investigators

  • George Ferzli, MD · Lutheran Medical Center

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00694278 on ClinicalTrials.gov